Journal of Clinical Endocrinology & Metabolism, Vol 63, 1-8, Copyright © 1986 by Endocrine Society

ARTICLES

Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration

GA Brent and JM Hershman

A randomized prospective study was done to assess the response of hypothyroxinemic patients with severe nonthyroidal illnesses to T4 therapy. Patients admitted to a medical intensive care unit who had a total serum T4 concentration less than 5 micrograms/dl were randomly assigned to a control (12 patients) or a T4 treatment group (11 patients). L-T4 in a dose of 1.5 micrograms/kg was given iv each day for 2 weeks. In the treatment group, serum T4 and free T4 concentrations significantly increased by day 3 and were normal on day 5. Serum TSH levels decreased significantly in the T4 treatment group, as did the TSH response to TRH. A significant rise in serum T3 occurred in the control group on day 7, but was delayed until day 10 in the treatment group. Mortality was equivalent in the 2 groups (75% control vs. 73% treatment). Regardless of group assignment, survivors and nonsurvivors were completely separable based on baseline T3 to T4 ratios [17.0 +/- 1.8 (+/- SE) ng/micrograms in survivors vs. 7.0 +/- 0.7 in nonsurvivors; P less than 0.001]. Angiotensin-converting enzyme was significantly reduced in the T4 treatment group, but did not rise significantly in response to treatment. T4 therapy was not beneficial in this population of intensive care unit patients, and by inhibiting TSH secretion, it may suppress an important mechanism for normalization of thyroid function during recovery.

This article has been cited by other articles:

				Y. Debaveye, B. Ellger, L. Mebis, T. J. Visser, V. M. Darras, and G. Van den Berghe Effects of Substitution and High-Dose Thyroid Hormone Therapy on Deiodination, Sulfoconjugation, and Tissue Thyroid Hormone Levels in Prolonged Critically Ill Rabbits Endocrinology, August 1, 2008; 149(8): 4218 - 4228. [Abstract] [Full Text] [PDF]

				M. S. Rothman, D. B. Arciniegas, C. M. Filley, and M. E. Wierman The Neuroendocrine Effects of Traumatic Brain Injury J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 363 - 372. [Abstract] [Full Text] [PDF]

				M. P. C. Siroen, M. A. E. van Bokhorst-de van der Schueren, M. C. Richir, H. P. Sauerwein, C. R. Leemans, J. J. Quak, and P. A. M. van Leeuwen The Prognostic Value of Severe Malnutrition in the Development of Nonthyroidal Illness in Head and Neck Cancer Patients JPEN J Parenter Enteral Nutr, September 1, 2006; 30(5): 415 - 420. [Abstract] [Full Text] [PDF]

				J. Yu and R. J. Koenig Induction of Type 1 Iodothyronine Deiodinase to Prevent the Nonthyroidal Illness Syndrome in Mice Endocrinology, July 1, 2006; 147(7): 3580 - 3585. [Abstract] [Full Text] [PDF]

				J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF]

				R. P. Peeters, S. van der Geyten, P. J. Wouters, V. M. Darras, H. van Toor, E. Kaptein, T. J. Visser, and G. Van den Berghe Tissue Thyroid Hormone Levels in Critical Illness J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6498 - 6507. [Abstract] [Full Text] [PDF]

				R. P. Peeters, P. J. Wouters, H. van Toor, E. Kaptein, T. J. Visser, and G. Van den Berghe Serum 3,3',5'-Triiodothyronine (rT3) and 3,5,3'-Triiodothyronine/rT3 Are Prognostic Markers in Critically Ill Patients and Are Associated with Postmortem Tissue Deiodinase Activities J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4559 - 4565. [Abstract] [Full Text] [PDF]

				H. C. Ho, A. D. Chapital, and M. Yu Hypothyroidism and Adrenal Insufficiency in Sepsis and Hemorrhagic Shock Arch Surg, November 1, 2004; 139(11): 1199 - 1203. [Abstract] [Full Text] [PDF]

				E. S. Nylen and B. Muller Endocrine Changes in Critical Illness J Intensive Care Med, March 1, 2004; 19(2): 67 - 82. [Abstract] [PDF]

				R. P. Peeters, P. J. Wouters, E. Kaptein, H. van Toor, T. J. Visser, and G. Van den Berghe Reduced Activation and Increased Inactivation of Thyroid Hormone in Tissues of Critically Ill Patients J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3202 - 3211. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				D. L Stewart, N. Ssemakula, D. R MacMillan, L J. Goldsmith, and L. N Cook Thyroid function in neonates with severe respiratory failure on extracorporeal membrane oxygenation Perfusion, December 1, 2001; 16(6): 469 - 475. [Abstract] [PDF]

				L. J. De Groot Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 151 - 164. [Full Text]

				G. Van den Berghe, F. de Zegher, and R. Bouillon Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1827 - 1834. [Full Text]

				K. B. Brosnihan, P. Li, D. Ganten, and C. M. Ferrario Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1908 - R1915. [Abstract] [Full Text] [PDF]

				G. Legradi, C. H. Emerson, R. S. Ahima, J. S. Flier, and R. M. Lechan Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus Endocrinology, June 1, 1997; 138(6): 2569 - 2576. [Abstract] [Full Text] [PDF]

				I. J. Chopra Euthyroid Sick Syndrome: Is It a Misnomer? J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 329 - 334. [Full Text] [PDF]

				J. D. Klemperer, I. Klein, M. Gomez, R. E. Helm, K. Ojamaa, S. J. Thomas, O. W. Isom, and K. Krieger Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery N. Engl. J. Med., December 7, 1995; 333(23): 1522 - 1527. [Abstract] [Full Text] [PDF]

				R. D. Utiger Altered Thyroid Function in Nonthyroidal Illness and Surgery -- To Treat or Not to Treat? N. Engl. J. Med., December 7, 1995; 333(23): 1562 - 1563. [Full Text]

				B. Murzi, G. Iervasi, S. Masini, R. Moschetti, V. Vanini, G. Zucchelli, and A. Biagini Thyroid Hormones Homeostasis in Pediatric Patients During and After Cardiopulmonary Bypass Ann. Thorac. Surg., February 1, 1995; 59(2): 481 - 485. [Abstract] [Full Text]

				S. Reichlin Neuroendocrine-Immune Interactions N. Engl. J. Med., October 21, 1993; 329(17): 1246 - 1253. [Full Text]

				J. Yu and R. J. Koenig Regulation of Hepatocyte Thyroxine 5'-Deiodinase by T3 and Nuclear Receptor Coactivators as a Model of the Sick Euthyroid Syndrome J. Biol. Chem., December 1, 2000; 275(49): 38296 - 38301. [Abstract] [Full Text] [PDF]